HealthcareServices

Global De-Identified Health Data Market Report 2026: Emerging Trends and Growth Scenarios

February 23, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the de-identified health data market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the De-Identified Health Data Market by the end of 2030?

The de-identified health data market has seen rapid expansion in recent years. This market is anticipated to expand from $9.2 billion in 2025 to $10.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.1%. The historical growth can be linked to the increased adoption of electronic health records, the rising demand for population health analytics, the expansion of clinical research databases, a growing focus on patient privacy compliance, and the increasing availability of structured healthcare data.

The de-identified health data market size is projected for substantial expansion over the upcoming years. Its valuation is anticipated to reach $16.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.7%. This expansion during the forecast timeframe is propelled by factors such as the increasing application of AI-driven health insights, greater investments in precision medicine research, the broadening scope of value-based care analytics, a heightened need for secure health data exchange, and the more extensive integration of real-world evidence into regulatory judgments. Key developments expected in this period encompass the proliferation of large-scale de-identified data platforms, the expanding utilization of real-world evidence analytics, a surging need for privacy-preserving data sharing frameworks, increased implementation of longitudinal patient data analysis, and the consolidation of multi-source healthcare datasets.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28191&type=smp

What Drivers Are Shaping Future Opportunities In The De-Identified Health Data Market?

The growing acceptance of electronic health records (EHRs) is projected to drive the expansion of the de-identified health data market in the coming years. Electronic health records (EHR) represent a digital version of an individual’s complete medical history, encompassing diagnoses, treatments, medications, laboratory results, and other health details, all securely stored and shared among authorized healthcare providers. The increased adoption of electronic health records is attributed to their capacity to improve patient care and safety through immediate and accurate access to comprehensive medical information. De-identified health data enhances these records by facilitating secure data sharing and advanced analytical processes while simultaneously protecting patient privacy, leading to better clinical decision-making and improved healthcare outcomes. For example, the National Center for Biotechnology Information, a US-based National Library of Medicine (NLM) under the U.S. National Institutes of Health (NIH), reported in 2024 that by August 2025, most hospitals had implemented patient engagement capabilities. These capabilities allowed patients to electronically view (99%), download (96%), and transmit (84%) their health information, such as test results, to a third party. Consequently, the increasing use of electronic health records (EHRs) is fueling the growth of the de-identified health data market.

Which Segment Groups Are Influencing The De-Identified Health Data Market?

The de-identified health data market covered in this report is segmented –

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

Which Trends Are Expected To Influence The De-Identified Health Data Market In The Upcoming Years?

Major companies operating in the de-identified health data market are concentrating on developing advanced solutions, such as real-world biomarker coverage applications, to support evidence-based healthcare decision-making. These applications utilize de-identified patient data to monitor and assess biomarker patterns and effectiveness across diverse populations outside clinical trials, thereby enabling researchers and healthcare providers to gain valuable insights into treatment responses and disease trends. For instance, in July 2025, Datma Inc., a US-based healthcare technology company, introduced the Federated Biomarker Explorer, a free application designed for pharmaceutical teams to quickly validate real-world biomarker coverage across Datma’s federated network of participating data contributors. This tool provides aggregate, cohort-level insights into biomarker presence, allowing teams to assess coverage rapidly without needing contracts or IT support. It also facilitates the secure integration of users’ own data for overlap analysis and aids in early-stage feasibility assessments through clinical and demographic filtering, helping to confirm that datasets include the necessary patient populations before committing resources.

Who Are The Prominent Global Companies Shaping The De-Identified Health Data Market Landscape?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The De-Identified Health Data Market?

North America was the largest region in the de-identified health data market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de-identified health data market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized De-Identified Health Data Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28191&type=smp

Browse Through More Reports Similar to the Global De-Identified Health Data Market 2026, By The Business Research Company

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Healthcare Data Integration Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-data-integration-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795